The Fisher Wallace Stimulator delivers a gentle electrical current to the brain via sponge electrodes in order to stimulate the production of serotonin, GABA, endorphins and other neurochemicals responsible for improving mood and sleep, and pain suppression. The device has also been shown to lower cortisol (stress hormone). In 1991, the FDA cleared the Fisher Wallace Stimulator for the treatment of depression, anxiety, insomnia and pain (post-surgical pain, acute traumatic pain and chronic pain).
Patients typically use the device at home for twenty minutes per treatment session, once or twice a day. You can use the device while reading a book or watching TV. Most patients do not feel the gentle electrical current, while others may feel a slight tingling sensation.
A prescription is required and may be written by a General Practitioner, Psychiatrist, Specialist, Registered Nurse, Chiropractor (for pain) or Acupuncturist (for pain). Please have your doctor fax your prescription to us at (800) 657-7362. You may also find a doctor who is familiar with our device by clicking here and entering your zip code.
Twenty years of published research, including a recent article by Harvard Medical School neuroscientist Felipe Fregni, MD, demonstrates the safety and effectiveness of the technology.
Fisher Wallace Laboratories works with a world-class medical advisory board that includes several of the nation's top psychiatrists.
Customers may return the device for a refund within 60 days of receipt if the device does not successfully treat their symptoms. A 10% restocking fee will be assessed, and shipping charges are not refundable.
There are no contraindications for using the device in conjunction with any medication. The only negative side effects associated with using the Fisher Wallace Stimulator are the rare occurrence of a mild headache, dizziness or mild skin irritation.
“I have seen very positive results, often within the first two weeks of using the Fisher Wallace Cranial Stimulator,” states Dr. Richard Brown, MD, Associate Clinical Professor of Psychiatry, Columbia Medical Center, “Approximately 75% of my patients who have been diagnosed with generalized anxiety disorder, major depressive disorder, stress related disorders or insomnia have reported positive changes.” Dr. Brown and his colleague at Columbia University, Dr. Andres San Martin, MD, have prescribed the Fisher Wallace Stimulator to hundreds of patients and report a 75% - 80% success rate. As of March 2011, Dr. Brown has treated over 400 patients with the device.
Fisher Wallace Laboratories continues groundbreaking research at Harvard Medical School, Columbia University, Massachusetts General Hospital, NYU Medical Center, University of Maryland, University of Toledo, and McLean Hospital (Harvard Medical School).
